Xie F - Search Results

1

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.

Lu H, Yang S, Zhu H, Tong X, Xie F, Qin J, Han N, Wu X, Fan Y, Shao YW, Mao W. Lu H, et al. Among authors: xie f. BMC Cancer. 2018 Mar 5;18(1):251. doi: 10.1186/s12885-018-4159-2. BMC Cancer. 2018. PMID: 29506494 Free PMC article.

2

Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.

Xie F, Liu H, Zhu YH, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y, Fu L, Guan XY. Xie F, et al. BMC Cancer. 2011 Feb 25;11:86. doi: 10.1186/1471-2407-11-86. BMC Cancer. 2011. PMID: 21352519 Free PMC article.

3

Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment.

Lu HY, Mao WM, Cheng QY, Chen B, Cai JF, Wang XJ, Wang Z, Xie FJ. Lu HY, et al. Oncol Lett. 2012 Jun;3(6):1288-1292. doi: 10.3892/ol.2012.666. Epub 2012 Apr 2. Oncol Lett. 2012. PMID: 22783435 Free PMC article.

4

Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer.

Lu HY, Zhang G, Cheng QY, Chen B, Cai JF, Wang XJ, Zhang YP, Wang Z, Lu ZY, Xie FJ, Mao WM. Lu HY, et al. Oncol Lett. 2012 Jul;4(1):89-93. doi: 10.3892/ol.2012.679. Epub 2012 Apr 12. Oncol Lett. 2012. PMID: 22807968 Free PMC article.

5

Adenovirus-mediated interferon-γ gene therapy induced human pancreatic carcinoma Capan-2 cell apoptosis in vitro and in vivo.

Xie FJ, Zhao P, Zhang YP, Liu FY, Nie XL, Zhu YH, Yu XM, Zheng QQ, Mao WM, Lu HY, Wei H, Huang W. Xie FJ, et al. Anat Rec (Hoboken). 2013 Apr;296(4):604-10. doi: 10.1002/ar.22661. Epub 2013 Feb 9. Anat Rec (Hoboken). 2013. PMID: 23401468 Free article.

6

Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

Zhu YH, Fu L, Chen L, Qin YR, Liu H, Xie F, Zeng T, Dong SS, Li J, Li Y, Dai Y, Xie D, Guan XY. Zhu YH, et al. Among authors: xie d, xie f. Cancer Res. 2013 Apr 1;73(7):2298-309. doi: 10.1158/0008-5472.CAN-12-2663. Epub 2013 Feb 22. Cancer Res. 2013. PMID: 23436800 Free article.

7

Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population.

Hong W, Wang K, Zhang YP, Kou JY, Hong D, Su D, Mao WM, Yu XM, Xie FJ, Wang XJ. Hong W, et al. J Zhejiang Univ Sci B. 2013 Mar;14(3):207-15. doi: 10.1631/jzus.B1200101. J Zhejiang Univ Sci B. 2013. PMID: 23463763 Free PMC article.

8

Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis.

Xie FJ, Zhang YP, Zheng QQ, Jin HC, Wang FL, Chen M, Shao L, Zou DH, Yu XM, Mao WM. Xie FJ, et al. World J Gastroenterol. 2013 Sep 28;19(36):6098-107. doi: 10.3748/wjg.v19.i36.6098. World J Gastroenterol. 2013. PMID: 24106412 Free PMC article. Review.

9

The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.

Xie FJ, Lu HY, Zheng QQ, Qin J, Gao Y, Zhang YP, Hu X, Mao WM. Xie FJ, et al. Onco Targets Ther. 2016 Jan 6;9:171-81. doi: 10.2147/OTT.S91848. eCollection 2016. Onco Targets Ther. 2016. PMID: 26793001 Free PMC article.

10

The role of histamine in opening blood-tumor barrier.

Wang Z, Cai XJ, Qin J, Xie FJ, Han N, Lu HY. Wang Z, et al. Oncotarget. 2016 May 24;7(21):31299-310. doi: 10.18632/oncotarget.8896. Oncotarget. 2016. PMID: 27121317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,522 results

Search Page

Filters